Cargando…

MIS-C is a risk factor for thrombotic events

Detalles Bibliográficos
Autor principal:	McHugh, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	In Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111652/ https://www.ncbi.nlm.nih.gov/pubmed/33976416 http://dx.doi.org/10.1038/s41584-021-00633-y

Ejemplares similares

MIS-C: how do patients fare 6 months on?
por: McHugh, Jessica
Publicado: (2021)

Thrombotic Events in MIS-C Patients: A Single Case Report and Literature Review
por: Maniscalco, Valerio, et al.
Publicado: (2023)

Thrombotic Complications in Children with COVID-19 and MIS-C
por: Kumar, Riten, et al.
Publicado: (2023)

Comparing paediatric COVID-19 with MIS-C
por: Bordon, Yvonne
Publicado: (2022)

Long-term anifrolumab safe in SLE
por: McHugh, Jessica
Publicado: (2023)

Multisystem inflammatory syndrome in children (MIS‐C) and the prothrombotic state: Coagulation profiles and rotational thromboelastometry in a MIS‐C cohort
por: Al‐Ghafry, Maha, et al.
Publicado: (2021)

Evaluation of antithrombotic prophylaxis and thrombotic events in children with COVID-19 or MIS-C: A tertiary pediatric center experience
por: Guner Ozenen, G., et al.
Publicado: (2023)

Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1
por: Lee, Pui Y., et al.
Publicado: (2020)

Risk factors for thrombotic events in Korean patients with systemic lupus erythematosus
por: Park, Dong-Jin, et al.
Publicado: (2021)

Multisystem inflammatory syndrome in children (MIS-C) and “Near MIS-C”: A continuum?
por: Khafaja, Sarah, et al.
Publicado: (2023)

Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome Diagnosis
por: Burguet, Laure, et al.
Publicado: (2022)

MIS-C Mimickers: A Case Series of Bacterial Enteritis and Sepsis Mistaken as MIS-C
por: K.C., Sudeep, et al.
Publicado: (2021)

MIS416 as a siRNA Delivery System with the Ability to Target Antigen-Presenting Cells
por: Mainini, Francesco, et al.
Publicado: (2018)

Enhanced Thrombotic Responses Are Associated With Striatin Deficiency and Aldosterone
por: Gromotowicz‐Poplawska, Anna, et al.
Publicado: (2021)

Risk of thrombotic events after respiratory infection requiring hospitalization
por: Smilowitz, Nathaniel R., et al.
Publicado: (2021)

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
por: Natsuaki, Masahiro, et al.
Publicado: (2018)

Antibiotic (Mis)Use in COVID-19 Patients before and after Admission to a Tertiary Hospital in Serbia
por: Despotović, Aleksa, et al.
Publicado: (2022)

A case of MIS-C presenting with fever and rash
por: Ho, Sarah, et al.
Publicado: (2023)

Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System
por: Perrella, Gina, et al.
Publicado: (2021)

Complement Inhibition in the Treatment of SLE-Associated Thrombotic Thrombocytopenic Purpura
por: Boneparth, Alexis, et al.
Publicado: (2015)

Incidence and risk factors of venous thrombotic events in patients with interstitial lung disease during hospitalization
por: Sun, Haishuang, et al.
Publicado: (2023)

Thrombotic events and COVID-19 vaccines
por: Brazete, C., et al.
Publicado: (2021)

Thrombotic Events Associated to Aspirin Therapy
por: Doutremepuich, Christian, et al.
Publicado: (2012)

Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C
por: Maddux, Aline B., et al.
Publicado: (2023)

Cytomorphology of nodular histiocytic/mesothelial hyperplasia
por: Jin, Xiaobing, et al.
Publicado: (2022)

Incidence rate of MIS‐C in paediatrics: A good reason to vaccinate children against SARS‐CoV‐2
por: Castagnola, Elio, et al.
Publicado: (2021)

Hemorrhagic Nonpurulent Conjunctivitis in MIS-C
por: Angurana, Suresh Kumar, et al.
Publicado: (2021)

Addressing fundamental questions on MIS-C
por: Davies, Patrick
Publicado: (2021)

Treatment of MIS-C in Children and Adolescents
por: Mahmoud, Sanaa, et al.
Publicado: (2022)

Revisiting MIS-C: Extending the Exclusions
por: Mishra, Ambrish Kumar, et al.
Publicado: (2022)

Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta‐analysis
por: Xiong, Xiaoming, et al.
Publicado: (2021)

Mis días y mis noches
por: Julie
Publicado: (1975)

Do Inpatients Receive Risk-Based Prophylactic Treatment for Thrombotic Events?
por: Nemani, Armin, et al.
Publicado: (2021)

The Role of Glucocorticoids in the Treatment of Multisystem Inflammatory Syndrome (MIS-C)—Data from POLISH MIS-C Registry
por: Gowin, Ewelina, et al.
Publicado: (2022)

Duffy‐null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia
por: Krecak, Ivan, et al.
Publicado: (2023)

Mortality risk factors among critically ill children with MIS-C in PICUs: a multicenter study
por: Sık, Guntulu, et al.
Publicado: (2023)

Thrombotic and Hemorrhagic Neurological Complications in Critically Ill COVID-19 Patients
por: Gonçalves, Bruno, et al.
Publicado: (2020)

Immune‐mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure
por: Joseph, Adrien, et al.
Publicado: (2022)

Mis-Spliced Lr34 Transcript Events in Winter Wheat
por: Fang, Tilin, et al.
Publicado: (2017)

New Thrombotic Events in Ischemic Stroke Patients with Elevated Factor VIII
por: Gouse, Brittany M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2rdug3q1e8fnq9ts25f42le2u7